1.Application of glutamine combined with dietary fibre and fructo-oligosaccharide in enteral nutrition support of elderly patients with mechanical ventilation
Yu PAN ; Lunqin WU ; Guangcheng LU
Chinese Journal of Geriatrics 2016;35(1):42-45
Objective To investigate the effects of enteral nutrition support with glutamine combined with dietary fibre and fructo oligosaccharide (GFO) on nutritional status, gastrointestinal function and outcome in elderly patients with mechanical ventilation.Methods Totally 90 patients were randomly divided into three group: the control group without additives (group A), enteral nutrition group with glutamine (group B) or with GFO (group C).Fasting blood samples were collected on day 1, 7 and 14 after the initiation of study, and then the indicators including hemoglobin, albumin, transferrin and prealbumin were determined.In addition, the gastrointestinal complications including bloating, diarrhea, and gastric retention were observed, and the mechanical ventilation time, length of intensive care unit (ICU) stay and extubation time were recorded.Results The serum transferrin and prealbumin levels were significantly improved on the 7th day (P=0.023 and 0.047),and the hemoglobin was significantly improved on the 14th day (P=0.003).4 cases in group B and 3 cases in group C underwent successful implementation of enteral nutrition, and 25 cases in group B and 27 cases in group C achieved the target volume of enteral nutrition, which were more than those in group A (P=0.008 and 0.000 respectively).The incidence of gastrointestinal complication was less in groups B and C than in group A.The mechanical ventilation time, length of ICU stay and extubation time were shorter in groups B and C than in group A.Conclusions Enteral nutrition with glutamine and GFO can improve nutritional status and reduce gastrointestinal complications in elderly patients with mechanical ventilation.Enteral nutrition with GFO has an advantage to the enteral nutrition and the outcome.
2.Effect of levothyroxine in the treatment of primary hypothyroidism
Meifang YAO ; Li YU ; Shaojun FANG ; Jianling ZHOU ; Guangcheng PAN
Chinese Journal of Primary Medicine and Pharmacy 2013;20(11):1611-1612
Objective To explore the influence of levothyroxine(L-T4) in the treatment of primary hypothyroidism on myocardial enzymes and lipids.Methods 78 patients with primary hypothyroidism were selected and treated with L-T4 for 12 weeks.The fasting serum levels promote thyroid hormone(TSH),free T3 (FT3),free T4 (FT4),total cholesterol (TC),triglycerides (TG),low-density lipoprotein cholesterol (LDL-C),aspartate aminotransferase enzyme (AST),creatine kinase (CK) and its isoenzyme (CK-MB),lactate dehydrogenase(LDH) were monitored and analyzed before and after treatment.Results After L-T4 treatment for 12 weeks,compared with before treatment,TSH,TC,TG,LDL-C,CK,CK-MB,LDH,AST were significantly decreased or restored (t =10.5223,26.8498,22.7699,16.2735,22.9329,13.1910,32.0907,22.9597,all P < 0.01).The FT3 was negatively correlated with TG (r =-0.3782),LDL-C(r =-0.3506),AST(r =-0.2843),LDH(r =-0.2974),CK(r =-0.3726) (all P < 0.01)and CK-MB(r =-0.2559) (P < 0.05).FT4 was negatively correlated with TC (r =-0.2660),TG (r =-0.4661),LDL-C(r=-0.5119),LDH(r=-0.5936),CK(r=-0.4877),CK-MB(r=-0.5463) (all P<0.01)and AST(r =-0.2328) (P <0.05).TSH was positively correlated with TC(r =0.5341),TG(r =0.7567),LDL-C(r =0.8240),AST (r =0.3923),LDH (r =0.8073),CK (r =0.9661),CK-MB (r =0.7336) (all P <0.01).TSH had,the best correlationship with CK (r =0.9661).Conclusion L-T4 can significantly improve the thyroid function and reduce the blood lipids,myocardial enzymes levels of patients with primary hypothyroidism.
3.Expert opinions on operation rules of Morita therapy outpatient service
Jiangbo LI ; Zucheng WANG ; Yuhua CUI ; Yingzhi LU ; Weijie QU ; Haiyin ZHANG ; Fuqiang MAO ; Fengqing QIE ; Wanghong SHI ; Qinfeng ZHANG ; Lingyi PAN ; Ling ZHANG ; Jianzhong LI ; Guangcheng CUI ; Tongxian CHEN ; Xiuqing MA ; Wei RONG ; Jianjun ZHANG ; Qingfang ZHONG ; Yanchi ZHANG ; Boquan ZHANG ; Xinrui WANG ; Wenyou MA ; Qingtao REN ; Yongfa JING ; Huanzhong LIU ; Zhenjian YU ; Laitian ZHAO ; Tianming HAN ; Xue HAN
Chinese Mental Health Journal 2024;38(1):68-72
Morita therapy has been bom for more than 100 years.Inpatient Morita therapy is highly oper-able and easy to master.It can improve many refractory neuroses through four-stage treatment.But more neuroses are treated in outpatient clinics,and Morita therapy cannot be used in hospitalized patients.Therefore,the formula-tion of expert opinions on outpatient operations is particularly important.This paper is based on domestic and for-eign references,and after many discussions by domestic Morita therapy experts,and then drew up the first version of the expert opinions on operation of outpatient Morita therapy.Meanwhile the operation rule of Morita therapy in three stages of outpatient treatment was formulated:in the etiological analysis stage,under the theoretical guidance of Morita therapy,analyze the pathogenic factors,to improve treatment compliance and reduce resistance;during the operating stage,guide patients to engage in constructive and meaningful actions,realizing the achievement of letting nature take its course principle;in the cultivating character and enriching life stage,pay attention to positive infor-mation,expanding the scope and content of actions,improving the ability to adapt to complex life,and preventing recurrence caused by insufficient abilities.It will lay a foundation for the promotion of Morita therapy in domestic outpatient clinics,so that more patients with neurosis and other psychological diseases could receive characteristic Morita therapy treatment in outpatient clinics.
4.Study on the Quality Standards of Miao Medicine Oxalis corniculata
Xue MA ; Yingying WU ; Yadu HE ; Guangcheng WANG ; Jie PAN ; Bao ZHANG ; Yongjun LI
China Pharmacy 2019;30(15):2091-2095
OBJECTIVE: To provide scientific basis for the utilization and development of Miao medicine Oxalis corniculata by promoting the quality standard of it. METHODS: Total of 12 batches of O. corniculata were collected from Guizhou, Anhui and Henan, etc. Microscopic characteristics of 12 batches of O. corniculata powder were observed. According to the corresponding methods in 2015 edition of Chinese Pharmacopoeia (part Ⅳ), TLC was used for qualitative identification [developing solvent was trichloromethane-methanol-formic acid (8 ∶ 1 ∶ 0.1, V/V/V)], and the contents of moisture, total ash, acid insoluble ash and alcohol soluble extractive from 12 batches of O. corniculata were determined. The content of isovitexin was determined by HPLC. The determination was performed on Venusil XBP C18 (L) with mobile phase consisted of acetonitrile-0.1% phosphoric acid solution (15 ∶ 85, V/V) at the flow rate of 1 mL/min. The column temperature was 35 ℃, and the detection wavelength was set at 338 nm. The sample size was 10 μL. RESULTS: Microscopic observation showed that the powder was grayish brown to yellowish brown, with many non-glandular hairs and obvious fibrous pore. Results of TLC identification showed that the spots of the same color appeared in the corresponding positions of the test and the control chromatogram. The contents of moisture, total ash, acid insoluble ash and alcohol soluble extract from samples were 6.66%-12.13%, 9.16%-13.79%, 1.58%-4.63% and 5.22%-15.79%, respectively. Results of HPLC method showed that the concentration of isovitexin showed a good linear relationship in the range of 5.20-78.3 μg/mL (r=0.999 0); RSDs of reproducibility (n=9), intermediate precision (n=6) and stability (24 h, n=6) tests were all lower than 2.0%; and the recovery rates were 97.54%-99.52% (RSD=0.74%, n=6); the contents of isovitexin in 12 batches of O. corniculata were 0.036%-0.144% (n=3). CONCLUSIONS: Qualitative and quantitative identification methods of O. corniculate were established, which can be used as a reference for improving the quality standard of O. corniculata.